Elixir Medical’s LithiX Hertz Contact IVL system receives CE Mark approval for treating calcified coronary lesions without external energy source.
As artificial intelligence becomes increasingly sophisticated in mimicking human interaction, psychologists warn that intimate relationships with AI companions present significant ethical challenges ranging from disruption of human bonds to potential manipulation and exploitation of vulnerable users.
A comprehensive evaluation of a green social prescribing programme in northern England has demonstrated that connecting people with nature-based activities can significantly improve mental health outcomes within just 12 weeks. The findings, published 16 April 2025 in Health & Social Care in the Community, highlight the potential for nature-based interventions to serve as effective therapeutic […]
Edwards Lifesciences has obtained European regulatory approval for its SAPIEN M3 system, making it the world’s first transcatheter mitral valve replacement therapy delivered via a transfemoral approach for treating mitral regurgitation.
Womed has launched its pioneering medical device designed to prevent intrauterine adhesions (IUA) across 14 European countries through new distribution partnerships with Kebomed Europe and Saesco Medical.
Philips has announced that its Radiology Operations Command Center Console has received EU Medical Device Regulation (MDR) certification for remote scanning capability, enabling expert radiologists to remotely control scans and assist technologists in real-time across multiple locations in Europe.
Baxter International Inc. has announced the European launch of its Hemopatch Sealing Hemostat with room temperature storage capability, eliminating the need for refrigeration and enabling immediate accessibility in operating theatres.
The European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.
New research reveals a rapid regenerative pathway activated minutes after liver injury through glutamate signalling between liver and bone marrow, offering potential therapeutic applications for liver damage.
Beckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
